Rochester, MNNCT06425380Now EnrollingIRB Ready

Hepatic Encephalopathy Clinical Trial in Rochester, MN

Access cutting-edge hepatic encephalopathy treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access hepatic encephalopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hepatic encephalopathy treatment provided free

Apply for This Rochester Location

Check if you qualify for this hepatic encephalopathy clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Hepatic Encephalopathy Study in Rochester

This research is studying how a food product (resistant potato starch) which is a dietary supplement made from potato starch affects the gut bacteria of people with cirrhosis and hepatic encephalopathy. The researchers in this study want to understand how potato starch works in the subject's body and how the body will react to it. Along with taking the study product participants health-related information and stool will be collected for this research study.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

Able to provide consent, with signed and dated informed consent form.
Stated willingness to comply with all study procedures and availability for the duration of the study.
Diagnosis of cirrhosis based on liver biopsy, imaging, or evidence of clinical decompensation.
History of at least one episode of overt Hepatic Encephalopathy (HE) in the last year.
Defined by West Haven Criteria Grades II to IV
Can be precipitated Hepatic Encephalopathy (HE) episode.
Sexually active women of childbearing potential enrolled in the study must agree to use a highly-effective method of contraception (defined in the protocol) for the duration of the study.

Exclusion Criteria

Hospitalization in the last 4 weeks
Current refractory ascites (requiring large volume paracentesis to manage ascites)
Gut-absorbable or intravenous antibiotic therapy in the last 4 weeks (rifaximin is permitted)
Anticipated antibiotics in the coming 4 weeks
Use of lactulose in the last 4 weeks
Alcohol or illicit drug intake in the last 4 weeks
Alcohol use will be characterized as \>1 alcoholic drink / week
History of inflammatory bowel disease
History of primary sclerosing cholangitis
Total bilirubin in the last 3 months \> 4 mg/dL
Prior diagnosis of dementia or other primary neurocognitive disorder
Pregnancy or breast feeding
Placement of a portosystemic shunt or transjugular intrahepatic portosystemic shunt in the last 3 months (permissible if placed \>3 months before enrollment)
Allergy to resistant potato starch

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT06425380) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hepatic Encephalopathy Treatment Options in Rochester, MN

If you're searching for hepatic encephalopathy treatment options in Rochester, MN, this clinical trial (NCT06425380) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatic encephalopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hepatic encephalopathy clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Hypertension Trials in Rochester, MN

See all pulmonary hypertension clinical trials recruiting in Rochester — not just this study.

Browse Pulmonary Hypertension Trials in Rochester →

Browse More Trials by Condition

Pulmonary Hypertension TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN